Laboratory Corporation of America(R) Holdings Announces Commencement of Offer to Purchase Its Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C., Aug 11, 2011 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (NYSE: LH) ("LabCorp") announced today that it is notifying holders of its Zero Coupon Convertible Subordinated Notes due 2021 (the "Notes") that they have the right, pursuant to the terms of the Notes,

LabCorp Clinical Trials Announces Strategic Alliance with David H. Murdock Research Institute to Offer Specialized Biomarker and Assay Development Services

BURLINGTON, N.C., Aug 10, 2011 (BUSINESS WIRE) -- Esoterix Clinical Trials Services, a division of Laboratory Corporation of America (R) Holdings (LabCorp (R) ) (NYSE: LH), today announced a strategic alliance with the David H. Murdock Research Institute (DHMRI) to provide its clients with access

Laboratory Corporation of America(R) Holdings Announces Second Quarter 2011 Results

Strong Volume and Revenue Growth Drives Adjusted EPS Excluding Amortization of $1.64 BURLINGTON, N.C., Jul 21, 2011 (BUSINESS WIRE) -- Laboratory Corporation of America (R) Holdings (LabCorp (R) ) (NYSE: LH) today announced results for the quarter ended June 30, 2011.

LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark Inc.

BURLINGTON, N.C., Jul 18, 2011 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (NYSE: LH) today announced that LabCorp is extending until 5:00 p.m., New York City time, on August 12, 2011, LabCorp's previously announced cash tender offer for all outstanding shares of the common

Conversion Right Triggered for LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C., Jul 01, 2011 (BUSINESS WIRE) -- Laboratory Corporation of America Holdings (LabCorp) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero Coupon Notes are convertible into cash and

LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark Inc.

BURLINGTON, N.C., Jun 16, 2011 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (NYSE: LH) today announced that LabCorp is extending until 5:00 p.m., New York City time, on July 15, 2011, LabCorp's previously announced cash tender offer for all outstanding shares of the common stock

LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark Inc.

BURLINGTON, N.C., Jun 02, 2011 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (NYSE: LH) today announced that LabCorp is extending until 6:00 p.m., New York City time, on June 15, 2011, LabCorp's previously announced cash tender offer for all outstanding shares of the common stock

LabCorp Enters into Definitive Agreement to Acquire Clearstone Central Laboratories

BURLINGTON, N.C. & TORONTO, Jun 01, 2011 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that it has entered into a definitive agreement to acquire Clearstone Central Laboratories, a leading global provider of central laboratory services for

LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark Inc.

BURLINGTON, N.C., May 18, 2011 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (NYSE: LH) today announced that LabCorp is extending until 6:00 p.m., New York City time, on June 1, 2011 LabCorp's previously announced cash tender offer for all outstanding shares of the common stock

LabCorp(R) Scheduled to Webcast Its Annual Meeting of Stockholders

BURLINGTON, N.C., May 09, 2011 (BUSINESS WIRE) -- Laboratory Corporation of America (R) Holdings (LabCorp (R) ) (NYSE: LH) today announced that its Annual Meeting of Stockholders will be webcast live beginning May 11, 2011 at 9:00 a.m. Eastern Time via the Company Web site at www.labcorp.com .